CHR Metz-Thionville

Metz 57085

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma, Follicle Center Lymphoma, Metastatic Breast Cancer

Studies at this site

• SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer — Completed
• Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy — Stopped early